Silvia Bertagnolio

Silvia is currently Unit Head in the Antimicrobial resistance (AMR) Division, at the World Health Organization (WHO) in Geneva. She leads the Organization’s work around AMR evidence generation for policy development and AMR laboratory strengthening and diagnostics.

At WHO, she also leads the WHO Global Clinical Platform for COVID-19, a global repository of anonymized clinical data of patients hospitalized for COVID-19 that inform the clinical characterization and public health responses to COVID-19.

Previous to this role, she led the HIV Drug Resistance (HIVDR) program at the World Health Organization in Geneva. In that role, she was responsible for the development of global strategies and policies, including the Global Action Plan on HIVDR. She coordinated the Global WHO HIVDR Laboratory Network and HIVDR surveillance program in over 50 low- and middle-income countries.

Silvia is qualified as a medical doctor specializing in Infectious Diseases from the Catholic University, Rome. She holds an academic affiliation with UCL, London, as an honorary senior research fellow.

She has been a Guest Editor of several journals, including the Journal of Infectious Diseases and Clinical Infectious Diseases, and published over 110 peer-reviewed papers, and book chapters.